Screening is an important aspect in early diagnosis and management of<unk><unk><unk>  (APS). The onset of APS is often with a single endocrine disorder and the subsequent involvement of other endocrine/non-endocrine organs may take up to years or decades. In patients of APS, high clinical suspicion should be maintained for presence of other<unk>  disorders. Once a patient has been diagnosed with a single<unk>  endocrine disorder, screening should be done for presence of other auto-antibodies such as 21- hydroxylase or 17-hydroxylase.
Autoimmune polyendocrine syndrome screening
Adrenal insufficiency screening
Hypopituitarism screening
Papillary thyroid cancer screening
Follicular thyroid cancer screening
Thyroid nodule screening
Medullary thyroid cancer screening
Multiple endocrine neoplasia type 1 screening